AADR vs BBP

Both AADR and BBP are ETFs. AADR has a lower 5-year return than BBP (8.92% vs 10.63%). AADR has a higher expense ratio than BBP (1.1% vs 0.79%). Below is the comparison between AADR and BBP.

AADR BBP
Segment Equity: Global Ex-U.S. - Total Market Growth Equity: U.S. Biotech
Issuer AdvisorShares Virtus
Net Assets $69.25M $24.95M
Expense Ratio 1.10% 0.79%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.68% 0.00%
Underlying Index -- LifeSci Biotechnology Products Index
YTD Return 7.55% 19.34%
1-Year Return 14.38% 18.10%
3-Year Return 1.15% 10.50%
5-Year Return 8.92% 10.63%
10-Year Return 7.88% N/A

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return 7.55%
1-Month Return 4.62%
3-Month Return 2.30%
1-Year Return 14.38%
3-Year Return 1.15%
5-Year Return 8.92%
10-Year Return 7.88%
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (46.22% of Total Assets)

Name Symbol % Assets
MercadoLibre Inc MELI.SA 5.89%
argenx SE ADR ARGX 5.63%
NICE Ltd ADR NICE 5.45%
Gold Fields Ltd ADR GFI.JO 5.07%
Galapagos NV ADR GLPG 4.76%
Anglogold Ashanti Ltd ADR AU.JO 4.67%
ZTO Express (Cayman) Inc ADR ZTO 4.27%
TAL Education Group ADR TAL 3.75%
ASML Holding NV ADR ASML 3.67%
AstraZeneca PLC ADR AZN.L 3.06%

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

BBP description

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. The Index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate.

BBP performance & returns

YTD Return 19.34%
1-Month Return 4.53%
3-Month Return 17.63%
1-Year Return 18.10%
3-Year Return 10.50%
5-Year Return 10.63%
10-Year Return N/A
BBP expense ratio is 0.79%.

BBP holdings

Top 10 Holdings (33.25% of Total Assets)

Name Symbol % Assets
Immunomedics Inc IMMU 5.61%
Aimmune Therapeutics Inc AIMT 3.93%
BeiGene Ltd ADR BGNE 3.57%
Sage Therapeutics Inc SAGE 3.45%
Momenta Pharmaceuticals Inc MNTA 3.45%
Akcea Therapeutics Inc AKCA 2.78%
Blueprint Medicines Corp BPMC 2.71%
Seattle Genetics Inc SGEN 2.64%
Amicus Therapeutics Inc FOLD 2.64%
Ultragenyx Pharmaceutical Inc RARE 2.47%

Other relevant BBP comparisons

You may also want to check out the following BBP comparisons that investors often look for on Finny

    Or use Finny Compare Wizard to create a comparison you’d like to see.

    You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.

    7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15 a month, without ads. Start a free trial. Go ad free!

    Follow Us